Journal of Pediatric Neurology 2016; 14(02): 075-077
DOI: 10.1055/s-0036-1584277
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Miller Fisher Syndrome Associated with Parvovirus B19 Infection in a Child

Filippo Greco
1   Unit of Clinical Pediatrics, Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy
,
Alice Le Pira
1   Unit of Clinical Pediatrics, Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy
,
Luisa Scalora
1   Unit of Clinical Pediatrics, Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy
,
Roberta Catania
1   Unit of Clinical Pediatrics, Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy
,
Tiziana Timpanaro
1   Unit of Clinical Pediatrics, Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy
,
Pierluigi Smilari
1   Unit of Clinical Pediatrics, Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy
,
Giovanni Sorge
1   Unit of Clinical Pediatrics, Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy
› Author Affiliations
Further Information

Publication History

18 September 2015

09 February 2016

Publication Date:
30 May 2016 (online)

Abstract

Miller Fisher syndrome (MFS) is a variant of Guillain–Barré syndrome, and it is typically characterized by the triad of ophthalmoplegia, ataxia, and areflexia. We report a 13-year-old boy affected with MFS associated with parvovirus B19 infection in which immunoglobulin (Ig)G and IgM anti-GQ1b antibodies were not detected. Treatment with intravenous Igs resulted in a progressive and rapid resolution of the clinical features. To our knowledge, this is the first example in the literature of seronegative anti-GQ1b antibody MFS associated with parvovirus B19 infection in childhood. The possible role of other gangliosides is discussed.